Evidence map›Paper›PMID 38927092›Full record

ReviewBiomolecules2024

Insights into the Role of Glutathione Peroxidase 3 in Non-Neoplastic Diseases.

Nan Zhang, Haihan Liao, Zheng Lin, Qizhu Tang

Abstract readReview
In one paragraph

Review in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nan ZhangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.ORCID 0000-0001-6690-4449
Haihan LiaoDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Zheng LinDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Qizhu TangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.ORCID 0000-0003-2210-3169

Funding

National Key R&D Program of China 2018YFC1311300Regional Innovation and Development Joint Fund of National Natural Science Foundation of China U22A20269The Fundamental Research Funds for the Central Universities 2042023kf0045
6 · The paper itself

Abstract

Reactive oxygen species (ROSs) are byproducts of normal cellular metabolism and play pivotal roles in various physiological processes. Disruptions in the balance between ROS levels and the body's antioxidant defenses can lead to the development of numerous diseases. Glutathione peroxidase 3 (GPX3), a key component of the body's antioxidant system, is an oxidoreductase enzyme. GPX3 mitigates oxidative damage by catalyzing the conversion of hydrogen peroxide into water. Beyond its antioxidant function, GPX3 is vital in regulating metabolism, modulating cell growth, inducing apoptosis and facilitating signal transduction. It also serves as a significant tumor suppressor in various cancers. Recent studies have revealed aberrant expression of GPX3 in several non-neoplastic diseases, associating it with multiple pathological processes. This review synthesizes the current understanding of GPX3 expression and regulation, highlighting its extensive roles in noncancerous diseases. Additionally, this paper evaluates the potential of GPX3 as a diagnostic biomarker and explores emerging therapeutic strategies targeting this enzyme, offering potential avenues for future clinical treatment of non-neoplastic conditions.

Indexed as

Glutathione PeroxidaseAnimalsAntioxidantsHumansNoncommunicable DiseasesOxidative StressReactive Oxygen SpeciesAntioxidantsGlutathione PeroxidaseGPX3 protein, humanReactive Oxygen Speciesgene expressionglutathione peroxidase 3non-neoplastic diseaseoxidative stressreactive oxygen species

Identifiers

PMID38927092
PMCPMC11202029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.